Infinity Pharmaceuticals | INFI - Ordinary Share Capital


Infinity Pharmaceuticals reported $90K in Ordinary Share Capital for its fiscal quarter ending in June of 2023.





Ordinary Share Capital Change Date
AbbVie USD 1.77B 1.75B Jun/2025
Alterity Therapeutics Limited AUD 10.88B 10.66B Dec/2025
Amgen USD 539M 1000K Dec/2025
AstraZeneca USD 1.55B 206K Dec/2025
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
Cipla INR 807.77M 807.43M Sep/2025
Clal Biotechnology ILS 1.61M 0 Dec/2022
Compugen USD 94.55M 1.02M Dec/2025
CSL USD 482.13M 93.87M Dec/2025
Eisai JPY 282.11M 1000 Dec/2025
Eli Lilly USD 946.83M 354.23M Jun/2025
Gilead Sciences USD 1.24B 1000K Dec/2025
GlaxoSmithKline GBP 4.08B 49.43M Dec/2025
Grifols EUR 680.58M 846.11K Dec/2025
Incyte USD 198.46M 2.33M Dec/2025
Infinity Pharmaceuticals USD 90K 1000 Jun/2023
Ionis Pharmaceuticals USD 161.97M 836K Dec/2025
J&J USD 2.41B 584K Sep/2025
Novartis USD 1.91B 10.64M Dec/2025
Pfizer USD 5.69B 1000K Sep/2025
Plus Therapeutics USD 138.68M 7.07M Dec/2025
Roche Holding CHF 795.62M 699.54K Dec/2025
TG Therapeutics USD 155.21M 2.81M Sep/2025